Scarica l'app Stockscreener
5.005
0.10%
-0.005
Dopo l'orario di chiusura:
4.95
-0.055
-1.10%
Precedente Chiudi:
$5.01
Aprire:
$5.02
Volume 24 ore:
22,439
Relative Volume:
1.91
Capitalizzazione di mercato:
$56.81M
Reddito:
$800.00K
Utile/perdita netta:
$-45.07M
Rapporto P/E:
-0.9518
EPS:
-5.2583
Flusso di cassa netto:
$-52.08M
1 W Prestazione:
+2.46%
1M Prestazione:
-12.50%
6M Prestazione:
-17.55%
1 anno Prestazione:
-43.83%
Intervallo 1D:
$4.93
$5.30
Intervallo di 1 settimana:
$4.73
$5.30
Portata 52W:
$3.94
$9.22
Imagenebio Inc Stock (IMA) Company Profile
Nome
Imagenebio Inc
Settore
Industria
Telefono
857-343-8292
Indirizzo
12526 HIGH BLUFF DRIVE, SAN DIEGO
Compare IMA vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMA
Imagenebio Inc
|
5.005 | 56.87M | 800.00K | -45.07M | -52.08M | -5.2583 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Imagenebio Inc Stock (IMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Ripresa | Wedbush | Underperform |
| 2025-10-24 | Iniziato | Leerink Partners | Outperform |
Imagenebio Inc Borsa (IMA) Ultime notizie
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York - The Manila Times
A biotech CEO will speak in New York. ImageneBio will archive the webcast for 90 days. - Stock Titan
ImageneBio, Inc. (NASDAQ: IMA) Share Price, IMA Stock News, IMA Share Price & Updates - Kalkine
IMA Q2 2026 Earnings: Narrower EPS Loss Beats Estimates, Shares Slip 6.4%Earnings Call Highlights - vinanet.vn
ImageneBio (IMA) Edges Higher to $5.34 as Bulls Defend Key SupportPost-Earnings Moves - vinanet.vn
ImageneBio (IMA) Market: Finishes 1.78% Lower at $5.51 in the Current Update; Technical View: the Price Remains Bounded by the Supplied Support and Resistance on the DayCorrective Wave - vinanet.vn
ImageneBio, Inc. (NASDAQ:IMA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
HC Wainwright Initiates ImageneBio at Buy With $28 Price Target - marketscreener.com
Blue Owl Capital Holdings LP Invests $5.41 Million in ImageneBio, Inc. $IMA - MarketBeat
ImageneBio (NASDAQ:IMA) Trading 1.8% HigherWhat's Next? - MarketBeat
ImageneBio Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ImageneBio (IMA) shifts CFO equity mix toward RSUs in new grant - Stock Titan
ImageneBio's New Hires Get Stock Awards as CFO Gets a Separate Award - Stock Titan
ImageneBio, Inc. (IMA): BVF group discloses 9.99% stake and large warrants - Stock Titan
ImageneBio, Inc. SEC Filing (Aug 12, 2026) - Stock Titan
IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally? - Stocktwits
ImageneBio Ord Shs (IMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ImageneBio, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Wedbush Maintains ImageneBio(IMA.US) With Sell Rating, Maintains Target Price $2 - Moomoo
William Blair Maintains ImageneBio(IMA.US) With Buy Rating - Moomoo
ImageneBio (IMA) registers 1.37M existing shares for resale on Form S-3 - Stock Titan
ImageneBio (IMA) sets up $200M shelf and $17M ATM stock program - Stock Titan
ImageneBio (IMA) files to register 5.77M warrant shares for investor resale - Stock Titan
ImageneBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ImageneBio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ImageneBio Sees Cash Runway Funding Planned Ops Into 1Q of 2028 >IMA - Moomoo
ImageneBio, Inc. Q2 2026: Revenue $0 EPS $(0.63) — 10-Q Summary - TradingView
ImageneBio Reports Second Quarter 2026 Financial Results - The Manila Times
ImageneBio Reports Second Quarter 2026 Financial Results and Corporate Update on Olevaprubart Clinical Development - Quiver Quantitative
ImageneBio reports Q2 2026: $136.2M cash; $10.2M net loss for quarter - TradingView
ImageneBio Posts $10.2 Million Q2 Loss With Cash Runway Into 2028 - Quiver Quantitative
ImageneBio (Nasdaq: IMA) details Q2 2026 loss and $136M cash runway - Stock Titan
IMA: Clinical pipeline advances and robust cash position support continued development through 2028 - TradingView
ImageneBio’s Atopic Dermatitis Data Anticipated in Q4 2027 - Stock Titan
IKNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
ImageneBio, Inc. Revenue Breakdown – NASDAQ:IMA - TradingView
ImageneBio Inc. (IMA) Q1 2026 Earnings: EPS Miss Highlights Pre‑Revenue Challenges as Stock Rises - dars.gov.et
ImageneBio (NASDAQ:IMA) Trading Up 2.9%Should You Buy? - MarketBeat
ImageneBio Ord Shs (IMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IMA|ImageneBio Ord Shs|Price:5.600| - TradingKey
ImageneBio, Inc. Revenue Breakdown – BOATS:IMA - TradingView
ImageneBio Inc. (IMA) Q1 2026 Earnings: EPS Misses Estimates Amid Continued R&D InvestmentTax Rate Impact - vinanet.vn
ImageneBio Inc. (IMA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
ImageneBio Strengthens Leadership with New CFO Appointment - TipRanks
ImageneBio (IMA) hires CFO with $450,000 salary and equity awards - Stock Titan
Imagenebio, Inc. Appoints Yanina Grant-Huerta as Chief Financial Officer, Effective July 20, 2026 - marketscreener.com
IMA Q1 2026 Earnings: Wider-Than-Expected Loss Reflects Continued R&D InvestmentOperating Margin Analysis - vinanet.vn
Form 4 ImageneBio Inc For: 21 July By Investing.com - Investing.com South Africa
ImageneBio principal accounting officer sells $17,334 in stock By Investing.com - Investing.com Nigeria
Imagenebio Inc Azioni (IMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):